Population
Mice
Comparison
Losartan vs control in chronic inhaled nicotine exposure
Design
Preclinical animal study
Answers are grounded in this paper and cite their sources.
Demonstrates that losartan ameliorates nicotine-induced pulmonary hypertension and right ventricular remodeling in mice, suggesting therapeutic utility of renin-angiotensin system blockers.
Chronic, inhaled nicotine causes pulmonary hypertension and right ventricular remodeling in mice. Treatment with losartan, an angiotensin II type 1 receptor antagonist, ameliorates nicotine-induced pulmonary hypertension and right ventricular remodeling. This novel finding provides preclinical evidence for the use of renin-angiotensin system-based therapies in the treatment of pulmonary hypertension, particularly in patients with a history of tobacco-product use.
No takes yet. Share an insight, caveat, or question.
Fried et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: